Case report of an unusual presentation of Staphylococcus aureus induced toxic shock syndrome/hyperimmunoglobulinemia E syndrome

Abstract Rationale: Toxic shock syndrome (TSS) typically is an acute onset multi-organ infection caused by TSS toxin-1 producing Staphylococcus aureus. Herein we describe a highly unusual case report. Patient concerns: A male patient self-referred to the University of Minnesota Hospital with a chronic history of S aureus infection with accompanying fever, hypotension, and nonhealing, football-sized lesion on his leg. Diagnosis: An unusual case presentation of TSS/hyperimmunoglobulin E syndrome is described. The patient had a leg wound from which TSS toxin-1 S aureus was isolated. The patient exhibited characteristic skewing of T cells to those with variable region, β-chain T cell receptor-2. Other patients have been seen with related presentations. Interventions: The following therapeutic regimen was instituted: vigorous antibacterial scrubs several times daily plus intravenous Ancef 3 days each month; intravenous infusions of immunoglobulin G infusions (28 gm) every 3 weeks; and weekly subcutaneous injections of recombinant granulocyte colony-stimulating factor. Outcome: Improvement was obvious within 3 months: no further cellulitic episodes occurred; the patient regained 95 pounds in 9 months; blanching and cyanosis of fingers disappeared within 3 months as did intractable pain although mild hypesthesias continued for 2 years; erythroderma resolved, and repeat skin biopsies performed after 2 years no longer demonstrated T cell receptor skewing. Although IgE levels have not completely returned to normal, the patient remains in excellent health. Lessons: We propose that staphylococcal TSST-1 was responsible for the serious problems suffered by this patient as suggested by the following features: rapid onset of chronic, life-threatening, disorder that began with an episode of staphylococcal sepsis; the extraordinary elevation of IgE levels in this previously non-atopic individual; the acquired severe granulocyte chemotactic defect that accompanied this hyperimmunoglobulinemia (“Job Syndrome”) with its accompanying wound-healing defect; and the striking diffuse erythroderma, including palmar erythema (“Red Man Syndrome”) with hypotension and fever that also characterizes TSS.

[1]  P. Schlievert,et al.  Staphylococcal and Streptococcal Superantigen Exotoxins , 2013, Clinical Microbiology Reviews.

[2]  B. Myones,et al.  Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. , 2002, The Journal of pediatrics.

[3]  P. Schlievert,et al.  Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. , 2000, FEMS microbiology letters.

[4]  P. Schlievert,et al.  The immunopathogenesis and management of Kawasaki syndrome. , 1998, Arthritis and rheumatism.

[5]  K. Sullivan,et al.  Association of Toxic Shock Syndrome Toxin-Secreting and Exfoliative Toxin-Secreting Staphylococcus aureus with Kawasaki Syndrome Complicated by Coronary Artery Disease , 1997, Pediatric Research.

[6]  J. Musser,et al.  Association of Erythrodermic Cutaneous T-Cell Lymphoma, Superantigen-Positive Staphylococcus aureus, and Oligoclonal T-Cell Receptor Vβ Gene Expansion , 1997 .

[7]  J. Musser,et al.  Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. , 1997, Blood.

[8]  F. Quimby,et al.  Superantigens in Kawasaki syndrome. , 1995, Clinical immunology and immunopathology.

[9]  P. Schlievert,et al.  Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome , 1993, The Lancet.

[10]  P. Marrack,et al.  Superantigens and their potential role in human disease. , 1993, Advances in immunology.

[11]  T. Kohsaka,et al.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Schmid,et al.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. , 1981, The Journal of infectious diseases.

[13]  P. Chesney,et al.  Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. , 1980, The New England journal of medicine.

[14]  G. Schmid,et al.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. , 1980, The New England journal of medicine.

[15]  J. Todd,et al.  TOXIC-SHOCK SYNDROME ASSOCIATED WITH PHAGE-GROUP-I STAPHYLOCOCCI , 1978, The Lancet.